跳至主要内容
临床试验/NCT07242105
NCT07242105招募中不适用

Optimized Methods for Measuring Brain Excitability in Depression

Stanford University2 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2025年10月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
145
试验地点
2
主要终点
Changes in Posterior EL-TEP Amplitude after spTMS

研究概览

简要总结

The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time Guidance for Enhancing TEPs (TARGET).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women, ages 18 to 65
  • Diagnosis of major depressive disorder, assessed through a Structured Clinical Interview for DSM-5 (SCID-5)
  • In a current depressive episode, assessed through a Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (SCID-5)
  • Moderate-to-severe depression as indicated by a score between 11-20 on the Quick Inventory of Depressive Symptoms (QIDS)
  • Must comprehend English well to ensure adequate comprehension of the EEG and TMS instructions, and of clinical scales
  • No current or history of neurological disorders
  • No seizure disorder or risk of seizures
  • Neurosurgical patients: Men and women ages 18-65 with medication-refractory epilepsy who are admitted for phase II intracranial monitoring to detect a seizure focus will be considered appropriate for this study. Participants must have the intellectual capacity to understand the consent process and agree to the study.

排除标准

  • Those with a contraindication for MRIs (e.g. implanted metal)
  • History of head trauma with loss of consciousness
  • History of seizures or on medications that reduce seizure threshold (e.g., olanzapine, chlorpromazine, lithium)
  • Neurological or uncontrolled medical disease
  • Any unstable medical condition
  • Active substance abuse
  • Diagnosis of psychotic or bipolar disorder
  • A prior history of Electroconvulsive Therapy (ECT) failure
  • History of suicide attempt in the past year
  • Currently pregnant or breastfeeding
  • Repetitive Transcranial Magnetic Stimulation (rTMS) treatment in the past six months

研究组 & 干预措施

Active TMS, Sham TMS with iEEG

Experimental

Neurosurgical participants receive both active single-pulse Transcranial Magnetic Stimulation (TMS) and sham single-pulse TMS delivered to predefined dlPFC sites while undergoing intracranial EEG recording. The order of active and sham stimulation is randomized.

干预措施: Active Single-Pulse TMS (Device)

Active TMS, Sham TMS with iEEG

Experimental

Neurosurgical participants receive both active single-pulse Transcranial Magnetic Stimulation (TMS) and sham single-pulse TMS delivered to predefined dlPFC sites while undergoing intracranial EEG recording. The order of active and sham stimulation is randomized.

干预措施: Sham Single-Pulse TMS (Device)

Active TMS, Sham TMS with iEEG

Experimental

Neurosurgical participants receive both active single-pulse Transcranial Magnetic Stimulation (TMS) and sham single-pulse TMS delivered to predefined dlPFC sites while undergoing intracranial EEG recording. The order of active and sham stimulation is randomized.

干预措施: Intracranial EEG (iEEG) Recording (Other)

Sham TMS, Active TMS with iEEG

Experimental

Neurosurgical participants receive sham single-pulse TMS followed by active single-pulse TMS at predefined dlPFC sites during intracranial EEG recording. The order of stimulation conditions is randomized.

干预措施: Active Single-Pulse TMS (Device)

Sham TMS, Active TMS with iEEG

Experimental

Neurosurgical participants receive sham single-pulse TMS followed by active single-pulse TMS at predefined dlPFC sites during intracranial EEG recording. The order of stimulation conditions is randomized.

干预措施: Sham Single-Pulse TMS (Device)

Sham TMS, Active TMS with iEEG

Experimental

Neurosurgical participants receive sham single-pulse TMS followed by active single-pulse TMS at predefined dlPFC sites during intracranial EEG recording. The order of stimulation conditions is randomized.

干预措施: Intracranial EEG (iEEG) Recording (Other)

Optimized TMS, Non-optimized TMS with EEG

Experimental

Participants receive both TARGET optimized single-pulse TMS and non-optimized (open-loop) single-pulse TMS to the dlPFC while undergoing concurrent scalp EEG. The sequence of optimized and non-optimized stimulation is randomized.

干预措施: TARGET-optimized TMS (Device)

Optimized TMS, Non-optimized TMS with EEG

Experimental

Participants receive both TARGET optimized single-pulse TMS and non-optimized (open-loop) single-pulse TMS to the dlPFC while undergoing concurrent scalp EEG. The sequence of optimized and non-optimized stimulation is randomized.

干预措施: Non-optimized (Open-Loop) TMS (Device)

Optimized TMS, Non-optimized TMS with EEG

Experimental

Participants receive both TARGET optimized single-pulse TMS and non-optimized (open-loop) single-pulse TMS to the dlPFC while undergoing concurrent scalp EEG. The sequence of optimized and non-optimized stimulation is randomized.

干预措施: EEG Recording (Other)

Non-optimized TMS, Optimized TMS with EEG

Experimental

Participants receive non-optimized (open-loop) single-pulse TMS followed by TARGET optimized single-pulse TMS to the dlPFC with concurrent scalp EEG. The order of stimulation conditions is randomized.

干预措施: TARGET-optimized TMS (Device)

Non-optimized TMS, Optimized TMS with EEG

Experimental

Participants receive non-optimized (open-loop) single-pulse TMS followed by TARGET optimized single-pulse TMS to the dlPFC with concurrent scalp EEG. The order of stimulation conditions is randomized.

干预措施: Non-optimized (Open-Loop) TMS (Device)

Non-optimized TMS, Optimized TMS with EEG

Experimental

Participants receive non-optimized (open-loop) single-pulse TMS followed by TARGET optimized single-pulse TMS to the dlPFC with concurrent scalp EEG. The order of stimulation conditions is randomized.

干预措施: EEG Recording (Other)

结局指标

主要结局

Changes in Posterior EL-TEP Amplitude after spTMS

时间窗: Baseline, end of spTMS (6 hours)

Changes in Early Local TMS-Evoked Potentials (EL-TEP) following 6 hours of either active or sham spTMS between optimized and non-optimized stimulation conditions in the posterior dlPFC.

Changes in Anterior EL-TEP Amplitude after single-pulse TMS (spTMS)

时间窗: Baseline, end of spTMS (6 hours)

Changes in Early Local TMS-Evoked Potentials (EL-TEP) following 6 hours of either active or sham spTMS between optimized and non-optimized stimulation conditions in the anterior dlPFC.

Changes in intracranial TMS-Evoked Potential (iTEP) Amplitude after TMS-iEEG

时间窗: Baseline, end of spTMS (20 minutes)

Changes in the interaction between gyral/sulcal targets and coil angles (45 vs 90 degrees) on local dlPFC iTEP amplitude.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Corey Keller

Associate Professor

Stanford University

研究点 (2)

Loading locations...

相似试验